Erectile dysfunction drug approved to treat BPH symptoms.
D002243:Carbolines / Q000627:therapeutic use*; D017277:Drug Approval; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D000068581:Tadalafil; D014481:United States; D014486:United States Food and Drug Administration; D014665:Vasodilator Agents / Q000627:therapeutic use
D002243:Carbolines; D014665:Vasodilator Agents; D000068581:Tadalafil